RPL5P2

Across TCGA pan-cancer cohorts, RPL5P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL5P2’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RPL5P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL5P2 is over-expressed in tumor, although a few such as KIRC and LUSC show the opposite, repressed pattern.

UCEC, KIRC, and LUSC are the cancer types where RPL5P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL5P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	+0.265	.014	4	view →
KIRC	All	All	−0.015	.011	4	view →
LUSC	Male	All	−0.025	.034	3	view →
THCA	All	All	−0.016	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPL5P2–UCEC

Open the UCEC breakdown →